iBio, Inc. IBIO Balance Sheet

Ibio, inc. (IBIO)

Balance Sheet / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11
Assets
Current assets:
Cash
10,040	3,637	2,103	4,421	9,037	13,361	16,010	15,934	3,398	7,310	5,916	8,088	12,422	16,329	20,098	23,014	21,893	6,732	8,384	9,494	8,080	7,363	3,486	3,590	4,333	5,678	3,444	4,414	1,526	2,818	4,276	5,624	6,724	623	1,522	2,843
Accounts receivable - trade
75	224	75	97	117	155	119	75	181	136	260	175	128	25	170	484	454	202	480	445	341	584	0	205	1,007	1,007	1,007	1,007	390	390	390	351	371	233	320	344
Contract assets
-	-	-	-	-	57	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts receivable - unbilled
-	-	-	-	-	-	-	-	-	-	-	-	0	75	62	122	-	15	126	0	325	338	555	-	-	-	-	-	-	-	-	-	-	-	-	-
Work in process
-	-	-	-	-	-	-	-	0	0	0	26	60	27	0	22	58	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses and other current assets
189	146	183	290	432	396	206	276	407	377	206	283	374	292	132	264	318	252	90	182	298	277	80	118	192	255	194	1,214	293	-	-	925	-	-	-	-
Prepaid expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	732	258	-	205	797	296	774
Other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	53	226	-	-	-	-	338
Other current assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	376	283	389	-
Total Current Assets
10,304	4,007	2,361	4,808	9,586	13,969	16,335	16,285	3,986	7,823	6,382	8,572	12,984	16,748	20,462	23,906	22,723	7,201	9,080	10,121	9,044	8,562	4,121	3,913	5,532	6,940	4,645	6,635	2,210	3,995	5,151	6,900	7,677	1,938	2,528	4,300
Finance lease right-of-use assets, net of accumulated amortization
28,031	28,446	28,862	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fixed assets, net of accumulated depreciation
2,657	2,658	2,594	24,380	24,641	24,812	24,981	25,152	25,335	25,289	25,268	25,589	25,794	25,453	25,580	25,574	25,775	14	10	13	14	17	20	6	7	5	5	6	4	4	2	3	6	6	7	8
Intangible assets, net of accumulated amortization
1,204	1,249	1,323	1,374	1,423	1,498	1,554	1,620	1,687	1,702	1,757	1,823	1,895	1,960	2,023	2,092	2,139	2,201	2,284	2,360	2,388	2,463	2,516	2,575	2,675	2,673	2,685	2,713	2,765	2,805	2,837	2,862	2,971	2,990	3,040	3,027
Security deposits
24	24	24	24	24	24	26	26	26	26	26	26	25	27	26	28	28	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	85	-	-
Total Assets
42,220	36,384	35,164	30,586	35,674	40,303	42,896	43,083	31,034	34,840	33,433	36,010	40,698	44,188	48,091	51,600	50,665	9,416	11,374	12,494	11,446	11,042	6,657	6,494	8,214	9,618	7,335	9,354	4,981	6,805	7,991	9,765	10,655	5,020	5,576	7,335
Liabilities and Equity
Current liabilities:
Accounts payable (related parties of $19 and $125 as of March 31, 2020 and June 30, 2019, respectively)
547	442	661	1,001	722	662	692	790	939	701	596	749	1,391	731	979	1,177	1,551	1,334	1,271	1,104	815	984	516	297	1,118	1,245	1,313	2,401	2,416	2,711	2,418	2,846	2,182	4,041	2,980	2,895
Accrued expenses (related party of $840 and $699 as of March 31, 2020 and June 30, 2019, respectively)
1,135	1,053	1,175	965	1,074	1,052	1,125	1,048	746	1,130	1,047	924	957	905	1,022	920	647	188	294	159	405	491	702	98	95	419	340	1,885	250	251	240	230	303	276	226	56
Notes payable - warrant exchange
1,196	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Finance lease obligation - current portion
295	216	139	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Capital lease obligation - current portion
-	0	0	213	209	205	201	197	194	190	187	183	180	176	173	170	167	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Contract liabilities
3,006	3,033	2,894	1,279	2,041	2,526	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
-	-	-	-	-	-	3,018	-	68	23	276	157	93	55	0	24	76	16	-	0	34	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Warrant derivative liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	16	125	760	520	1,314	396	1,483	4,187
Total Current Liabilities
6,179	4,744	4,869	3,458	4,046	4,445	5,036	2,035	1,947	2,044	2,106	2,013	2,621	1,867	2,174	2,291	2,441	-	-	1,263	-	1,475	1,218	-	1,213	1,664	1,653	4,286	2,683	3,088	3,419	3,596	3,801	4,714	4,690	7,139
Finance lease obligation - net of current portion
32,084	32,160	32,235	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Capital lease obligation - net of current portion
0	0	0	24,671	24,726	24,780	24,832	24,884	24,935	24,985	25,034	25,082	25,129	25,175	25,220	25,265	25,308	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities
38,263	36,904	37,104	28,129	28,772	29,225	29,868	26,919	26,882	27,029	27,140	27,095	27,750	27,042	27,394	27,556	27,749	1,538	1,565	1,263	1,254	1,475	1,218	395	-	-	-	-	-	-	-	-	-	-	-	-
Commitments and Contingencies
-	-	-	-	-	-	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0
Equity:
iBio, Inc. Stockholders' Equity:
Preferred Stock, Value, Issued
-	-	0	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Common stock - $0.001 par value; 275,000,000 shares authorized; 107,360,032 and 20,152,458 shares issued and outstanding as of March 31, 2020 and June 30, 2019, respectively
107	55	24	20	20	19	18	16	116	115	93	9	89	89	89	89	83	77	77	77	74	72	68	66	66	64	57	57	47	47	47	48	47	32	32	32
Common stock to be issued; 1,200,000 shares at December 31, 2013 and 0 shares at June 30, 2013
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	480	-	-	-	-	-	-	-	-	-	-
Additional paid-in capital
150,774	135,071	108,359	108,295	108,236	108,188	105,670	104,408	87,877	87,574	82,178	81,057	80,680	67,974	67,733	67,468	63,127	59,712	59,398	59,006	56,086	53,774	47,986	47,235	46,995	46,191	42,782	42,547	38,468	38,129	37,912	37,459	36,781	27,149	26,132	25,826
Accumulated other comprehensive loss
-33	-31	-32	-31	-31	-30	-31	-30	-29	-29	-29	-29	-29	-29	-29	-29	-31	-33	-34	-25	-26	-14	-3	0	-	-	-	-	-	-	-	-	-	-	-	-
Accumulated deficit
-146,882	-135,606	-110,284	-105,821	-101,318	-97,095	-92,626	-88,228	-83,810	-79,848	-75,949	-72,123	-67,794	-63,881	-60,652	-57,591	-54,914	-51,878	-49,632	-47,827	-45,942	-44,265	-42,612	-41,202	-40,060	-38,781	-37,157	-37,536	-36,218	-34,460	-33,389	-31,338	-29,975	-26,876	-25,278	-25,661
Total iBio, Inc. Stockholders' Equity
3,966	-511	-1,933	2,463	6,907	11,082	13,031	16,166	4,154	7,812	6,293	8,914	12,946	4,153	7,141	9,937	8,265	7,878	9,809	11,231	10,192	9,567	5,439	6,099	7,001	7,954	5,682	5,068	2,297	3,716	4,571	6,169	6,854	305	886	196
Noncontrolling interest
-9	-9	-7	-6	-5	-4	-3	-2	-2	-1	0	1	2	12,993	13,556	14,107	14,651	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Equity
3,957	-520	-1,940	2,457	6,902	11,078	13,028	16,164	4,152	7,811	6,293	8,915	12,948	17,146	20,697	24,044	22,916	-	-	11,231	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities and Equity
42,220	36,384	35,164	30,586	35,674	40,303	42,896	43,083	31,034	34,840	33,433	36,010	40,698	44,188	48,091	51,600	50,665	9,416	11,374	12,494	11,446	11,042	6,657	6,494	8,214	9,618	7,335	9,354	4,981	6,805	7,991	9,765	10,655	5,020	5,576	7,335
Series A Preferred Stock [Member]
Preferred Stock, Value, Issued
0	0	0	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Series B Preferred Stock [Member]
Preferred Stock, Value, Issued
0	0	0	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Series C Preferred Stock [Member]
Preferred Stock, Value, Issued
0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
iBio CMO [Member]
Preferred Stock, Value, Issued
0	0	-	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-